Sign in

CIK 0001490978 · Large accelerated filer

Schrodinger, Inc.

Sign in to watch
Ticker
SDGR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
954284541
Phone
503-299-1150
Business address
1540 BROADWAY, 24TH FLOOR, NEW YORK, NY, 10036
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,781,663
in 3 filings, $2.8M under 10b5-1 plans

Net −$2,781,663. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-06-18 GINSBERG GARY L Director Grant or award · Stock Option (right to buy) +8,550 8,550
2024-03-21 Abel Robert Lorne See Remarks Grant or award · Stock Option (right to buy) +30,000 30,000
2024-03-21 Lorton Kenneth Patrick EVP, CTO & COO, Software Grant or award · Stock Option (right to buy) +30,000 30,000
2024-03-06 Lorton Kenneth Patrick EVP, CTO & COO, Software Option exercise +5,574 $4.34 $24K 42,061
2024-03-06 Lorton Kenneth Patrick EVP, CTO & COO, Software Option exercise · Stock Option (right to buy) −5,574 0
2024-03-04 Porges Geoffrey Craig EVP & CFO Grant or award +9,000 9,000
2024-03-04 Porges Geoffrey Craig EVP & CFO Sale −3,315 $26.35 $87K 5,685
2024-03-04 Porges Geoffrey Craig EVP & CFO Grant or award · Stock Option (right to buy) +90,000 90,000
2024-03-04 Farid Ramy President & CEO Grant or award · Stock Option (right to buy) +126,000 126,000
2024-03-04 Farid Ramy President & CEO Grant or award · Stock Option (right to buy) +87,271 87,271
2024-03-04 Herman Jenny SVP & Controller Grant or award +7,313 19,074
2024-03-04 Herman Jenny SVP & Controller Grant or award · Stock Option (right to buy) +14,625 14,625
2024-03-04 Lorton Kenneth Patrick EVP, CTO & COO, Software Grant or award · Stock Option (right to buy) +60,000 60,000
2024-03-04 Akinsanya Karen President of R&D, Therapeutics Grant or award · Stock Option (right to buy) +120,000 120,000
2024-03-04 Tran Yvonne EVP, CLO & CPO Grant or award · Stock Option (right to buy) +60,000 60,000
2024-03-04 Dugan Margaret Chief Medical Officer Grant or award · Stock Option (right to buy) +60,000 60,000
2024-03-04 Abel Robert Lorne See Remarks Grant or award · Stock Option (right to buy) +60,000 60,000
2024-02-12 Tran Yvonne EVP, CLO & CPO Sale 10b5-1 −758 $28.29 $21K 11,963
2024-02-12 Abel Robert Lorne See Remarks Sale 10b5-1 −1,205 $27.55 $33K 9,340
2024-02-12 Herman Jenny SVP & Controller Sale 10b5-1 −787 $28.29 $22K 11,761

Page 9 of 11 · 214 trades